Sea Cucumbers Metabolites as Potent Anti-Cancer Agents
- PMID: 25984989
- PMCID: PMC4446612
- DOI: 10.3390/md13052909
Sea Cucumbers Metabolites as Potent Anti-Cancer Agents
Abstract
Sea cucumbers and their extracts have gained immense popularity and interest among researchers and nutritionists due to their nutritive value, potential health benefits, and use in the treatment of chronic inflammatory diseases. Many areas of the world use sea cucumbers in traditional foods and folk medicine. Though the actual components and their specific functions still remain to be investigated, most sea cucumber extracts are being studied for their anti-inflammatory functions, immunostimulatory properties, and for cancer prevention and treatment. There is large scope for the discovery of additional bioactive, valuable compounds from this natural source. Sea cucumber extracts contain unique components, such as modified triterpene glycosides, sulfated polysaccharides, glycosphingolipids, and esterified phospholipids. Frondanol A5, an isopropyl alcohol/water extract of the enzymatically hydrolyzed epithelia of the edible North Atlantic sea cucumber, Cucumaria frondosa, contains monosulfated triterpenoid glycoside Frondoside A, the disulfated glycoside Frondoside B, the trisulfated glycoside Frondoside C, 12-methyltetradecanoic acid, eicosapentaenoic acid, and fucosylated chondroitin sulfate. We have extensively studied the efficacy of this extract in preventing colon cancer in rodent models. In this review, we discuss the anti-inflammatory, immunostimulatory, and anti-tumor properties of sea cucumber extracts.
Keywords: Frondanol A5; aberrant crypt foci; anti-inflammation; colon cancer; sea cucumber.
Figures



Similar articles
-
Frondoside A is a potential anticancer agent from sea cucumbers.J Cancer Res Ther. 2019 Jul-Sep;15(5):953-960. doi: 10.4103/jcrt.JCRT_1427_16. J Cancer Res Ther. 2019. PMID: 31603094 Review.
-
Frondoside A of Cucumaria frondosa (Gennerus, 1767): Chemistry, biosynthesis, medicinal applications, and mechanism of actions.J Pharm Pharmacol. 2025 Jan 6;77(1):32-42. doi: 10.1093/jpp/rgae059. J Pharm Pharmacol. 2025. PMID: 38843504 Review.
-
Immunomodulatory properties of frondoside A, a major triterpene glycoside from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa.J Med Food. 2008 Sep;11(3):443-53. doi: 10.1089/jmf.2007.0530. J Med Food. 2008. PMID: 18800890
-
High-value components and bioactives from sea cucumbers for functional foods--a review.Mar Drugs. 2011;9(10):1761-1805. doi: 10.3390/md9101761. Epub 2011 Oct 10. Mar Drugs. 2011. PMID: 22072996 Free PMC article. Review.
-
Chemopreventive effects of Frondanol A5, a Cucumaria frondosa extract, against rat colon carcinogenesis and inhibition of human colon cancer cell growth.Cancer Prev Res (Phila). 2010 Jan;3(1):82-91. doi: 10.1158/1940-6207.CAPR-09-0112. Cancer Prev Res (Phila). 2010. PMID: 20051375
Cited by
-
Holospiniferoside: A New Antitumor Cerebroside from The Red Sea Cucumber Holothuria spinifera: In Vitro and In Silico Studies.Molecules. 2021 Mar 12;26(6):1555. doi: 10.3390/molecules26061555. Molecules. 2021. PMID: 33809026 Free PMC article.
-
The Anti-Cancer Effects of Frondoside A.Mar Drugs. 2018 Feb 19;16(2):64. doi: 10.3390/md16020064. Mar Drugs. 2018. PMID: 29463049 Free PMC article. Review.
-
Sea Cucumber and Blueberry Extracts Suppress Inflammation and Reduce Acute Lung Injury through the Regulation of NF-κB/MAPK/JNK Signaling Pathway in Lipopolysaccharide-Treated C57BL/6 Mice.Molecules. 2024 Mar 28;29(7):1511. doi: 10.3390/molecules29071511. Molecules. 2024. PMID: 38611791 Free PMC article.
-
Cytotoxic Potential of the Coelomic Fluid Extracted from the Sea Cucumber Holothuria tubulosa against Triple-Negative MDA-MB231 Breast Cancer Cells.Biology (Basel). 2019 Oct 9;8(4):76. doi: 10.3390/biology8040076. Biology (Basel). 2019. PMID: 31600896 Free PMC article.
-
Structures and Bioactivities of Six New Triterpene Glycosides, Psolusosides E, F, G, H, H1, and I and the Corrected Structure of Psolusoside B from the Sea Cucumber Psolus fabricii.Mar Drugs. 2019 Jun 14;17(6):358. doi: 10.3390/md17060358. Mar Drugs. 2019. PMID: 31207953 Free PMC article.
References
-
- Rajasekaran A., Sivagnanam G., Xavier R. Nutraceuticals as therapeutic agents: A review research. J. Pharm. Technol. 2008;1:328–340.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous